Does adherence to using a product intended to prevent HIV acquisition depend on willingness, or ability to use the product? What are the factors — whether thoughts, beliefs, structural obstacles or social barriers — influencing both? The challenges that women have faced since the recognition of HIV in protecting themselves from getting the virus by […]
With pregnant women facing higher chances of acquiring HIV and greater dangers of life-threatening complications as a result of HIV, in addition to risks of passing the virus to their children, some of the most ambitious and promising developments in HIV prevention will be those that allow women to protect themselves both from the virus and from unplanned pregnancies, researchers at the HPTN annual meeting said.
With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers […]
Here at the Microbicides 2010 conference in Pittsburgh I got a chance to talk with Dr. Gita Ramjee, one of the top researchers in the field, about the most exciting scientific challenges being discussed at the meeting. Dr Ramjee is the Director of the HIV Prevention Research Unit at the South African Medical Research Council. […]
This post is by the Global Center’s David Bryden, who is attending the 2010 International Microbicides Conference this week in Pittsburgh. Stay tuned for more coverage of this important conference. An exciting conference on microbicides for HIV prevention has gotten underway in Pittsburgh, Penn. There is an air of anticipation at the meeting because some of the […]
If there’s any question about the value of U.S. investments in scientific research on HIV/AIDS, Anthony Fauci probably put it to rest today by noting that in the period since HIV first emerged, “we went from a 26-week lifespan to a 40-year-plus life span” for those infected with the virus. Talk about measureable outcomes. That […]
Willard Cates, Jr., MD, MPH, President, Research, Family Health International, recently gave a provocative presentation at a Microbicides Trial Network meeting in Washington, D.C., providing insights about the potential public health impact of microbicides, if the scientific evidence demonstrates efficacy in preventing HIV transmission. We spoke with Dr. Cates about the challenges of translating scientific […]
The National Institutes of Health is seeking grant applications for its Microbicide Innovation Program. The agency is looking for projects that will advance the development of new microbicides or shed new light on the characterization of microbicides for use against HIV or STIs linked to HIV, among other scientific pursuits. Here’s the link for […]